Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Danny, Zakria"'
Autor:
Joshua Burshtein, Milaan Shah, Danny Zakria, Benjamin Lockshin, Jeff Crowley, Joseph F. Merola, Ken Gordon, Mona Shahriari, Neil J. Korman, Raj Chovatiya, Robert Kalb, Mark Lebwohl
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 2, Pp 323-339 (2024)
Abstract Introduction Psoriasis is a chronic inflammatory condition affecting the skin, joints, and several other organ systems with significant disease burden. Bimekizumab is the first monoclonal antibody targeting both interleukin (IL)-17A and inte
Externí odkaz:
https://doaj.org/article/5d0a3eb8c3af4834a758e9dc334fd9fd
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Externí odkaz:
https://doaj.org/article/b3fe517498fd4e3890033f3c720ccb80
Autor:
Georgia Sofia Karachaliou, Rached Alkallas, Sarah B. Carroll, Chongshan Caressi, Danny Zakria, Nirali M. Patel, Dimitri G. Trembath, Jennifer A. Ezzell, Guillaume J. Pegna, Paul B. Googe, Jonathan P. Galeotti, Fatih Ayvali, Frances A. Collichio, Carrie B. Lee, David W. Ollila, Margaret L. Gulley, Douglas B. Johnson, Kevin B. Kim, Ian R. Watson, Stergios J. Moschos
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Melanoma-intrinsic activated β-catenin pathway, the product of the catenin beta 1 (CTNNB1) gene, has been associated with low/absent tumor-infiltrating lymphocytes, accelerated tumor growth, metastases development, and resistance
Externí odkaz:
https://doaj.org/article/e37d57623fe24adeb9a71ff470be1281
Autor:
Lisa Zimmer, Serigne Lo, Celeste Lebbe, Olivier Michielin, Ines Pires da Silva, Paolo Antonio Ascierto, Matteo Carlino, Alexander Menzies, Douglas B Johnson, Claudia Trojanello, Georgina Long, Tasnia Ahmed, Clara Allayous, Johanna Mangana, Florentia Dimitriou, Danny Zakria, Camille Gerard
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Background Patients with V600BRAF mutant metastatic melanoma have higher rates of progression-free survival (PFS) and overall survival (OS) with first-line anti-PD1 (PD1]+anti-CTLA-4 (IPI) versus PD1. Whether this is also true after BRAF/MEKi therapy
Externí odkaz:
https://doaj.org/article/21c29e95030742fcaad36b5414ae6fcf
Autor:
Danny Zakria, April Armstrong, Brian Berman, James Del Rosso, Mark Lebwohl, Todd Schlesinger, Darrell Rigel
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 7:752-763
Background: Actinic keratosis (AK) is one of the most common dermatologic diagnoses. While there are several treatment options, many topical therapies have poor adherence due to duration of treatment and local skin reactions (LSRs). Objective: To rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c2c71caa906da1b4421c544ce4bca77
https://doi.org/10.25251/skin.7.3.1
https://doi.org/10.25251/skin.7.3.1
Autor:
Danny Zakria, Nicholas Brownstone, Brian Berman, Roger Ceilley, Gary Goldenberg, Mark Lebwohl, Graham Litchman, Daniel Siegel
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 7:556-569
Background: Cutaneous melanoma (CM) guidelines put forth by the eighth edition of the American Joint Committee on Cancer (AJCC8) and the National Comprehensive Cancer Network (NCCN) do not currently account for lesion genomics when assessing prognosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::179da95967ac85c730e03cc8dc345172
https://doi.org/10.25251/skin.7.1.1
https://doi.org/10.25251/skin.7.1.1
Publikováno v:
Journal of Drugs in Dermatology. 22:101-104
Studies suggest potential heterogeneity in telemedicine adoption with potential to exacerbate healthcare access inequity.A pre-validated survey was electronically sent to a proprietary listserv of practicing US-based dermatologists. Results were stra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d345a88b28e80c673611035352eb0d
https://doi.org/10.36849/jdd.7169
https://doi.org/10.36849/jdd.7169
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 6:463-473
Introduction: National guidelines for cutaneous melanoma suggest avoiding sentinel lymph node biopsy (SLNB) if the risk of SLN positivity is 10% (T2-T4). Because most patients (88%) who undergo an SLNB have a negative result, novel tools to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c99594b84af7d267e6c30a868e7fe03
https://doi.org/10.25251/skin.6.6.3
https://doi.org/10.25251/skin.6.6.3
Publikováno v:
Melanoma Research. 33:80-83
The purpose of this study was to investigate whether EIS technology can further improve correct biopsy choices beyond clinical and dermoscopic evaluation for melanoma (MM), severe dysplastic nevi (SDN) and benign PSLs. Images of 49 MMs, SDNs and beni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdeca56cd2406b0ae902d9cb5f3a86ef
https://doi.org/10.1097/cmr.0000000000000859
https://doi.org/10.1097/cmr.0000000000000859
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 6:189-194
not available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93f235b31935e47d063e2e5ebd1b544c
https://doi.org/10.25251/skin.6.3.2
https://doi.org/10.25251/skin.6.3.2